Maintenance Therapy Following Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia

Yongxian Hu,Hong‐Hu Zhu
DOI: https://doi.org/10.1007/978-981-99-3810-0_14
2023-01-01
Abstract:Allogeneic hematopoietic stem cell transplantation (allo-HSCT) has significantly improved the outcome of patients with acute myeloid leukemia (AML). However, the relapse rate is still high, accounting for about half of treatment failures. Administration of maintenance therapy after allo-HSCT is therefore needed to prevent relapse. Different strategies and cellular therapies after allo-HSCT have been initiated as maintenance therapy to enhance graft-versus-leukemia effects, reduce the relapse rate, and eventually improve OS. In this chapter, we will review the current maintenance therapy following allo-HSCT.
What problem does this paper attempt to address?